Global Sleep Apnea Diagnostic and Therapeutic Devices Industry
NEW YORK, Feb. 2, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Sleep Apnea Diagnostic And Therapeutic Devices Industry
This report analyzes the worldwide markets for Sleep Apnea Diagnostic and Therapeutic Devices in US$ Million by the following Product Segments: Diagnostic Devices (Fixed PSG, Ambulatory PSG, & Others (include Screening Devices)), and Therapeutic Devices (CPAP, Bi-Level PAP, Auto PAP, & Facial Interfaces (Masks and Humidifiers)). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 57 companies including many key and niche players worldwide such as Astro-Med Inc., Grass Technologies, Cadwell Laboratories, Inc., CareFusion Corporation, Compumedics Ltd., DeVilbiss Healthcare, Embla Systems, evo Medical Solutions, Inc., Fisher & Paykel Healthcare Limited, Itamar Medical Ltd., Invacare Corporation, Natus Medical Inc., Bio-Logic, Stellate Systems, Inc., Philips Healthcare, ResMed Inc., Teleflex Medical, Vital Signs Inc., and Weinmann Geräte für Medizin GmbH+CCo. KG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES MCP-3307
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
Diagnostic Devices 3
Fixed PSG 3
Ambulatory PSG 3
Others (include Screening Devices) 4
Therapeutic Devices 4
CPAP 4
Bi-Level PAP 4
Auto PAP 4
Facial Interfaces (Masks and Humidifiers) 4
2. MARKET DYNAMICS 5
Recession and Medical Device Industry 5
Outlook 6
Diagnostic Devices 6
Therapeutic Devices 6
Issues & Trends 6
Substantial Undiagnosed Patient Base Presents Lucrative
Opportunities 6
Changing Demographics to Play a Major Role 7
Increased Awareness of Comorbid Conditions Spurs Market Growth 7
Technology Advancements Improve Patient Compliance 7
Automated CPAP 8
Humidification 8
Patient-Friendly Masks 8
Educational Campaigns 8
Under-Penetration in CPAP Therapy Promises Significant Growth
Prospects 8
Industry Witnesses Consistent M&A Activity 9
3. COMPETITION AND MARKET STRUCTURE 10
Respironics and Resmed Dominate Competitive Landscape 10
Table 1: Global OSA Market (2007): Percentage Breakdown of
Market Share by Leading Players - ResMed, Respironics,
Fisher & Paykel Healthcare, Tyco/Puritan Bennett,
DeVilbiss, and Others (includes corresponding Graph/Chart) 10
Table 2: Global Market for Sleep Therapy (2008): Percentage
Share of Select Players in Terms of Revenues (includes
corresponding Graph/Chart) 10
Table 3: Global Market for Sleep Therapy (2008): Percentage
Share of Select Players in Terms of Revenues Generated
Outside the US (includes corresponding Graph/Chart) 11
4. SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES - A SYNOPSIS 12
Significance of Sleep 12
Stages of Sleep 12
Sleep Disorders and Stages of Sleep 12
Sleep Apnea- Introduction 12
Forms of Apnea 13
Central Sleep Apnea 13
Physiological Effects of CSA 13
Mixed Apnea 13
Complex Sleep Apnea 14
Obstructive Sleep Apnea - An Overview 14
History 14
Prevalence 15
Causes of OSA 15
Symptoms of OSA 15
Snoring and OSA 16
Risks and Complications Associated with Untreated Disorder 16
Risk Groups 16
Co-Morbid Conditions 16
Heart Failure 16
Hypertension 17
Diabetes 17
Fatigue 17
Complications Associated with Surgery and Medications 17
Financial Implications of Untreated OSA 17
Pediatric OSA 17
OSA Diagnosis 18
Interpreting AHI 18
AHI of 5 to 15: Mild OSA 18
AHI of 15 to 30: Moderate OSA 19
AHI of more than 30: Severe OSA 19
Monitoring and Recording Technologies 19
Polysomnography (PSG) 19
Fixed Polysomnographs 19
Ambulatory Polysomnographs 20
Screening Devices 20
Actigraphs 20
OSA Therapies 21
Positive Airway Pressure (PAP) Treatment 21
Continuous Positive Airway Pressure (CPAP) 21
Optional Features Available for CPAP Devices 21
Bilevel Positive Airway Pressure (BiPAP) 22
Auto-titrating Positive Airway Pressure (APAP) 22
Masks 23
Alternative Apnea Therapies 23
Oral Appliances 23
Surgical Procedures 23
Tracheostomy 23
Uvulo-palato-pharyngoplasty (UPPP) 24
Mandibular Myotomy 24
Laser Assisted Uvuloplasty (LAUP) 24
Somnoplasty or Radio Frequency (RF) Procedure 24
Pillar Palatal Implant System 24
Other Surgical Therapies 25
Over-the-Counter and Pharmacological Therapies 25
Behavioral and Lifestyle Changes 25
5. RESEARCH UPDATES 26
Research Finds Link Between Sleep Apnea and Heart Risks in
Children 26
Sleep Disorders Increase Risk for Stroke and Blood Pressure
Patients 26
Individuals with Sleep Apnea Face Greater Risk of Cardiac
Stress During Air Travel 26
Sleep Apnea Screening Reduces Risk of Post Operative
Complications 26
6. PRODUCT LAUNCHES/INTRODUCTIONS 27
GE Healthcare Launches MARS® Virtual Sleep Lab 27
ResMed Launches S9 Series in Europe 27
Remote Analysis Launches iPhone Sleep Diagnostic Application 27
Circadiance Unveils New Zzzephyr Seal 28
Philips Launches New Sleep Therapy System 28
ImThera Medical Unveils aura6000TM Neurostimulation System 28
Philips Unveils Respironics Products in India 28
CardioNet Introduces SomNet Cardiac Indicator 28
Manipal Cure and Care Unveils Snorben in India 29
Covidien Launches Sandman Intro CPAP Device with Heated
Humidifier 29
Itamar Medical Unveils Extended-Feature Sleep Diagnosis System 29
Weinmann Introduces Modular Masks 29
Respironics Rolls Out New Series of Masks 30
Fisher & Paykel Introduces Opus™ Nasal Pillows Mask 30
Fisher & Paykel Introduces SleepStyle 200 Auto Series Generators 30
RespCare Introduces Hybrid™ CPAP Interface 30
Teleflex Launches ConchaTherm® Neptune™ Heated Humidifier 30
Teleflex Medical Unveils New Series of Bravo Mask 31
ResMed Rolls Out Mirage Swift Series of Lightweight Masks 31
Weinmann Launches SOMNObalance 31
Weinmann Rolls Out SOMNOcheck 2 R& K 31
Cardinal Introduces Respiratory System for Infants 31
Respironics Releases New Headgear for OSA Patients 32
Teijin Launches Compact CPAP Device 32
Hoffman Launches Wearable CPAP Device 32
Respironics Introduces REMstar Plus M Sleep System 32
Puritan Unveils New Nasal Mask 32
Teleflex Introduces Hybrid Universal Interface 32
7. RECENT INDUSTRY ACTIVITY 33
Coliseum Northside Hospital Opens Sleep Disorder Center 33
Naturs Design Signs Partnership with Intus Healthcare 33
Graymark Healthcare and Coryell Memorial Healthcare Ink Agreement 33
Compumedics Obtains FDA Approval for GRAEL™ HD-PSG Sllep System 33
Covidien Sells Sleep Therapy and Bi-level Products to PH Invest 33
Embla Snaps Up Covidien's Sleep Diagnostic Business 34
Graymark Healthcare Signs Joint Venture Agreement with
Oklahoma Heart Hospital 34
Ethicon Takes Over Acclarent 34
Siix to Develop Sleep Disorders Tracking Device 34
Blue Shield and Apria Healthcare Ink Agreement Group 35
Peak Surgical Inks Distribution Agreement with Medtronic 35
REM Medical, U.S. Health Works Enter into Partnership 35
Graymark Healthcare Takes Over somniTech and somniCare 35
ResMed Takes Over Laboratoires Narval 36
Curative Medical Snaps Up BEVT 36
Roadside Medical Clinic + Lab Enters into Joint Venture with
Sleep Pointe 36
Air Liquide Takes Over Comcare Medical 36
REM Medical Takes Over Tucson Site of PsyPharma Global 36
Formation of CareFusion 37
FDA Grants 510(K) Clearance to Dormio Tech 37
Ambu Acquires Sleepmate Technologies 37
CIRCADIANTM Enters into Partnership with Sleep Pointe™ for
Providing OSA Detection and Cure 37
Medtronic Acquires Restore Medical 37
Blackstone to Take Over Apria Healthcare 38
Nihon Kohden Acquires Neurotronics 38
Medtronic Snaps Up Repose GAHM Product Line of InfluENT Medical 38
GE Healthcare Acquires Vital Signs 38
CleveMed Enters into Collaboration with BIDMC Professor 39
8. STRATEGIC CORPORATE DEVELOPMENTS IN THE RECENT PAST -
A PERSPECTIVE BUILDER 40
Royal Philips Acquires Respironics 40
Cardinal Health Signs Agreement with SleepNet 40
Nihon Kohden Signs New Agreement with Premier 40
Tyco Healthcare is Now Covidien 40
Natus Acquires XLTEK 41
Breas Medical Gets Clearance from FDA to Market iSleep 20i 41
ResMed Recalls 300,000 S8 Flow Generators 41
Compumedics Strikes Distribution Agreement with Medigas 41
Cardinal Health Takes Over VIASYS Healthcare 41
VIASYS Acquires Tiara Medical 42
Natus Acquires Bio-logic Systems 42
9. FOCUS ON SELECT PLAYERS 43
Astro-Med Inc. (US) 43
Grass Technologies (US) 43
Cadwell Laboratories, Inc. (US) 43
CareFusion Corporation (USA) 43
Compumedics Ltd (Australia) 44
DeVilbiss Healthcare (US) 44
Embla Systems (US) 44
evo Medical Solutions, Inc. (US) 44
Fisher & Paykel Healthcare Limited (New Zealand) 45
Itamar Medical Ltd. (Israel) 45
Invacare Corporation (US) 45
Natus Medical Inc. (US) 46
Bio-Logic (US) 46
Stellate Systems, Inc. (Canada) 46
Philips Healthcare (USA) 46
ResMed Inc. (US) 47
Teleflex Medical (US) 47
Vital Signs Inc. (US) 47
Weinmann Geräte für Medizin GmbH+CCo. KG (Germany) 47
10. GLOBAL MARKET PERSPECTIVE 49
Table 4: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 49
Table 5: World Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 50
Table 6: World 11-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2005, 2010, and 2015 (includes
corresponding Graph/Chart) 51
Table 7: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic Devices by Geographic Region - US,
Japan, Europe and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 52
Table 8: World Historic Review for Sleep Apnea Diagnostic
Devices by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 53
Table 9: World 11-Year Perspective for Sleep Apnea Diagnostic
Devices by Geographic Region - Percentage Breakdown of Value
Sales for US, Japan, Europe and Rest of World Markets for
Years 2005, 2010, and 2015 (includes corresponding
Graph/Chart) 54
Table 10: World Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic Devices by Product Segment -
Clinical/Fixed PSG, Ambulatory PSG, and Other Devices
(Screening Devices) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 55
Table 11: World Historic Review for Sleep Apnea Diagnostic
Devices by Product Segment - Clinical/Fixed PSG, Ambulatory
PSG, and Other Devices (Screening Devices) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 56
Table 12: World 11-Year Perspective for Sleep Apnea Diagnostic
Devices by Product Segment - Percentage Breakdown of Value
Sales for Clinical/Fixed PSG, Ambulatory PSG, and Other
Devices (Screening Devices) Markets for Years 2005, 2010, and
2015 (includes corresponding Graph/Chart) 56
Table 13: World Recent Past, Current & Future Analysis for
Clinical/Fixed PSG Devices by Geographic Region - US, Japan,
Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 57
Table 14: World Historic Review for Clinical/Fixed PSG Devices
by Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 58
Table 15: World 11-Year Perspective for Clinical/Fixed PSG
Devices by Geographic Region - Percentage Breakdown of Value
Sales for US, Japan, Europe and Rest of World Markets for
Years 2005, 2010, and 2015 (includes corresponding
Graph/Chart) 59
Table 16: World Recent Past, Current & Future Analysis for
Ambulatory PSG Devices by Geographic Region - US, Japan,
Europe and Rest of World Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 60
Table 17: World Historic Review for Ambulatory PSG Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 61
Table 18: World 11-Year Perspective for Ambulatory PSG Devices
by Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 62
Table 19: World Recent Past, Current & Future Analysis for
Other Diagnostic Devices (Screening Devices) by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 63
Table 20: World Historic Review for Other Diagnostic Devices
(Screening Devices) by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 64
Table 21: World 11-Year Perspective for Other Diagnostic
Devices (Screening Devices) by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2005, 2010, and 2015 (includes
corresponding Graph/Chart) 65
Table 22: World Recent Past, Current & Future Analysis for
Sleep Apnea Therapeutic Devices by Geographic Region - US,
Japan, Europe and Rest of World Markets Independently Analyzed
with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 66
Table 23: World Historic Review for Sleep Apnea Therapeutic
Devices by Geographic Region - US, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 67
Table 24: World 11-Year Perspective for Sleep Apnea
Therapeutic Devices by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2005, 2010, and 2015 (includes
corresponding Graph/Chart) 68
Table 25: World Recent Past, Current & Future Analysis for
Sleep Apnea Therapeutic Devices by Product Segment - CPAP,
Auto CPAP, Bi-Level CPAP, and Facial Interfaces (Masks and
Humidifiers) Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 69
Table 26: World Historic Review for Sleep Apnea Therapeutic
Devices by Product Segment - CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 70
Table 27: World 11-Year Perspective for Sleep Apnea
Therapeutic Devices by Product Segment - Percentage Breakdown
of Value Sales for CPAP, Auto PAP, Bi-Level PAP, and Facial
Interfaces (Masks and Humidifiers) Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 71
Table 28: World Recent Past, Current & Future Analysis for
CPAP Devices by Geographic Region - US, Japan, Europe and Rest
of World Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 72
Table 29: World Historic Review for CPAP Devices by Geographic
Region - US, Japan, Europe and Rest of World Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 73
Table 30: World 11-Year Perspective for CPAP Devices by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 74
Table 31: World Recent Past, Current & Future Analysis for
Auto PAP Devices by Geographic Region - US, Japan, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 75
Table 32: World Historic Review for Auto PAP Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 76
Table 33: World 11-Year Perspective for Auto PAP Devices by
Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 77
Table 34: World Recent Past, Current & Future Analysis for
Bi-Level PAP Devices by Geographic Region - US, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 78
Table 35: World Historic Review for Bi-Level PAP Devices by
Geographic Region - US, Japan, Europe and Rest of World
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 79
Table 36: World 11-Year Perspective for Bi-Level PAP Devices
by Geographic Region - Percentage Breakdown of Value Sales for
US, Japan, Europe and Rest of World Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 80
Table 37: World Recent Past, Current & Future Analysis for
Facial Interfaces (Masks and Humidifiers) by Geographic Region -
US, Japan, Europe and Rest of World Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 81
Table 38: World Historic Review for Facial Interfaces (Masks
and Humidifiers) by Geographic Region - US, Japan, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 82
Table 39: World 11-Year Perspective for Facial Interfaces
(Masks and Humidifiers) by Geographic Region - Percentage
Breakdown of Value Sales for US, Japan, Europe and Rest of
World Markets for Years 2005, 2010, and 2015 (includes
corresponding Graph/Chart) 83
11. THE UNITED STATES 84
A.Market Analysis 84
Outlook 84
Trends and Issues 84
Market Continues to Grow Despite Recession 85
Sleep Apnea Population and Penetration 85
Home Sleep Testing (HST) 85
Pricing Trends 85
Pricing Erosion on the Rise 85
Premium Products to Command Higher Prices 86
Reimbursement Scenario 86
Reimbursement Changes to Boost OSA Market 86
Home Sleep Tests Pose Significant Risk for Clinical PSGs 87
Reimbursement Scenario in Diagnostic and Therapy Devices 87
Reimbursement Rates of CPAP Equipment (New Devices): 2010
(In US$) 88
Average Replacement Schedules 89
Competitive Landscape - A Historic Review 90
Table 40: US Market for Sleep Diagnostics Devices (2006) -
Percentage Breakdown of Revenues for Covidien (formerly
Tyco), Embla, Respironics, Cardinal Health/Viasys,
Compumedics, Grass Technologies, Bio -Logics (Natus) and
Others (includes corresponding Graph/Chart) 90
Table 41: US Market for Sleep Therapy (2008) - Percentage
Breakdown of Revenues for Respironics, ResMed, Fisher &
Paykel, Covidien and Others (includes corresponding
Graph/Chart) 90
Distribution 90
A Review of the Sleep Service Providers Market 91
Greater Awareness Drives Trend Towards More Number of Beds
Per Facility 91
Table 42: Number of Sleep Facilities in the US: 1997-2007
(includes corresponding Graph/Chart) 91
Changeover of the Sleep Lab 92
Inadequate Sleep Labs - a Bottle Neck for Diagnosis of OSA 92
Inadequate Sleep Labs Surge Development of Portable Sleep
Monitoring 92
DME Market for Sleep Apnea Devices 93
Table 43: US Market for CPAP Devices (2006) - Percentage
Breakdown of Value Sales by Durable Medical Equipment (DME)
Suppliers for Apria Healthcare Group, Lincare Holdings Inc,
National Companies and Local Operators (includes
corresponding Graph/Chart) 93
B.Market Analytics 94
Table 44: US Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory
PSG, and Others (Screening Devices)), and Therapeutic
Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces
(Masks and Humidifiers)) Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 94
Table 45: US Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 95
Table 46: US 11-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Percentage
Breakdown of Value Sales for Diagnostic Devices (Clinical/
Fixed PSG, Ambulatory PSG, and Others (Screening Devices)),
and Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets for Years
2005, 2010, and 2015 (includes corresponding Graph/Chart) 96
12. JAPAN 97
A.Market Analysis 97
Outlook 97
Overview 97
B.Market Analytics 98
Table 47: Japanese Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 98
Table 48: Japanese Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 99
Table 49: Japanese 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets for Years 2005, 2010, and 2015
(includes corresponding Graph/Chart) 100
13. EUROPE 101
A.Market Analysis 101
Outlook 101
Sleep Apnea Diagnostics - A Growing Market 101
Trends & Issues 101
Ambulatory PSGs Gaining over Clinical PSGs 101
Competition 102
Table 50: European Sleep Diagnostics Market (2007) -
Percentage Breakdown of Revenues for Embla, Respironics,
Weinmann, Compumedics and Others (includes corresponding
Graph/Chart) 102
B.Market Analytics 103
Table 51: European Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Geographic Region - France, Germany, Italy, UK, Spain and
Rest of Europe Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 103
Table 52: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
France, Germany, Italy, UK, Spain and Rest of Europe Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart) 104
Table 53: European 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany,
Italy, UK, Spain and Rest of Europe Markets for Years 2005,
2010, and 2015 (includes corresponding Graph/Chart) 105
Table 54: European Recent Past, Current & Future Analysis
for Sleep Apnea Diagnostic and Therapeutic Devices by
Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 106
Table 55: European Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 107
Table 56: European 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2005, 2010, and 2015 (includes corresponding
Graph/Chart) 108
13a. FRANCE 109
A.Market Analysis 109
Outlook 109
B.Market Analytics 109
Table 57: French Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 109
Table 58: French Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 110
Table 59: French 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2005, 2010, and 2015 110
13b. GERMANY 111
A.Market Analysis 111
Outlook 111
Overview 111
B.Market Analytics 112
Table 60: German Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 112
Table 61: German Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 113
Table 62: German 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2005, 2010, and 2015 113
13c. ITALY 114
Market Analysis 114
Table 63: Italian Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 114
Table 64: Italian Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 115
Table 65: Italian 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2005, 2010, and 2015 115
13d. THE UNITED KINGDOM 116
A.Market Analysis 116
Outlook 116
Snapshots 116
B.Market Analytics 117
Table 66: UK Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 117
Table 67: UK Historic Review for Sleep Apnea Diagnostic and
Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 118
Table 68: UK 11-Year Perspective for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Percentage
Breakdown of Value Sales for Sleep Apnea Diagnostic Devices
and Sleep Apnea Therapeutic Devices Markets for Years 2005,
2010, and 2015 118
13e. SPAIN 119
Market Analysis 119
Table 69: Spanish Recent Past, Current & Future Analysis for
Sleep Apnea Diagnostic and Therapeutic Devices by Product
Segment - Sleep Apnea Diagnostic Devices and Sleep Apnea
Therapeutic Devices Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 119
Table 70: Spanish Historic Review for Sleep Apnea Diagnostic
and Therapeutic Devices by Product Segment - Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 120
Table 71: Spanish 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2005, 2010, and 2015 120
13f. REST OF EUROPE 121
Market Analysis 121
Table 72: Rest of Europe Recent Past, Current & Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment - Sleep Apnea Diagnostic Devices and
Sleep Apnea Therapeutic Devices Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 121
Table 73: Rest of Europe Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic
Devices Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 122
Table 74: Rest of Europe 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Sleep Apnea
Diagnostic Devices and Sleep Apnea Therapeutic Devices
Markets for Years 2005, 2010, and 2015 122
14. REST OF WORLD 123
A.Market Analysis 123
Outlook 123
Overview of Select Markets 123
Australia 123
Significant Demand for Sleep Apnea Therapeutic Devices 123
Market Shares and Players 124
Table 75: Australian Sleep Apnea Therapeutic Devices
Market (2007) - Percentage Breakdown of Value Sales for
ResMed, Respironics, Fisher & Paykel, Covidien and Others
(includes corresponding Graph/Chart) 124
Distribution 124
Table 76: Australian Sleep Apnea Therapeutic Devices
Market (2007) - Percentage Breakdown of Value Sales by
Major Distribution Channels (includes corresponding
Graph/Chart) 124
India - A High Potential Market 124
B.Market Analytics 125
Table 77: Rest of World Recent Past, Current & Future
Analysis for Sleep Apnea Diagnostic and Therapeutic Devices
by Product Segment - Diagnostic Devices (Clinical/Fixed PSG,
Ambulatory PSG, and Others (Screening Devices)), and
Therapeutic Devices (CPAP, Auto PAP, Bi-Level PAP, and
Facial Interfaces (Masks and Humidifiers)) Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 125
Table 78: Rest of World Historic Review for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, and
Others (Screening Devices)), and Therapeutic Devices (CPAP,
Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks and
Humidifiers)) Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 126
Table 79: Rest of World 11-Year Perspective for Sleep Apnea
Diagnostic and Therapeutic Devices by Product Segment -
Percentage Breakdown of Value Sales for Diagnostic Devices
(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening
Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level
PAP, and Facial Interfaces (Masks and Humidifiers)) Markets
for Years 2005, 2010, and 2015 (includes corresponding
Graph/Chart) 127
COMPETITION
Total Companies Profiled: 57 (including Divisions/Subsidiaries - 116)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 41
Canada 9
Japan 3
Europe 43
France 4
Germany 12
The United Kingdom 6
Italy 4
Spain 3
Rest of Europe 14
Asia-Pacific (Excluding Japan) 15
Latin America 2
Middle East 2
Africa 1
------------------------------------------
To order this report:
Diagnostics Industry: Global Sleep Apnea Diagnostic And Therapeutic Devices Industry
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article